The Role of Accurate Monitoring in Holistic Diabetes Management
According to Professor Partha Kar, National Specialty Advisor, Diabetes, NHS England and co-lead of Diabetes GIRFT, NHS ...
Glucose monitors for diabetes have finally been funded – but there's a problem
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
Click2Houston9d
‘We love this fairly low-risk intervention’: Over-the-counter device is helping people gain insight into their health
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
Taiwan News12d
Continuous Glucose Monitoring Systems Market Insights, Advances in Diabetes Management, 2024 to 2032
The global continuous glucose monitoring systems (CGMS) market was valued at approximately USD 6,626.6 million in 2021 and is expected to grow to USD 31,708.2 million by 2032, with a CAGR of 17.0% ...
Abbott Q3: Strong Growth In Medical Device And Pharma
Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
Abbott4d
Strong Performance by Abbott’s Base Business Drives Q3 Earnings
Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...
Joplin Globe2d
RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
RLF Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights ...
Morningstar10d
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
Senseonics' Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by ...